Table 5 Characteristics of adverse drug events (N = 148)
|  | Control (N = 65) | Intervention (N = 83) |
|---|---|---|
ADEs reported by the patient and/or his GPa | ||
 ADE reported by GPs only, % (n) | 20.0 (13) | 16.8 (14) |
 ADE reported by patients only, % (n) | 52.3 (34) | 68.7 (57) |
 ADE reported by GPs and patients, % (n) | 27.7 (18) | 14.5 (12) |
 ADE total, % (n) | 100.0 (65) | 100.0 (83) |
Symptomsb | ||
 Dizziness or light-headedness or Syncope (fainting) or vertigo, % (n) | 30.8 (20) | 12.1 (10) |
 Fatigue or asthenia or drowsiness, % (n) | 23.1 (15) | 15.7 (13) |
 Leg oedema, % (n) | 15.4 (10) | 12.1 (10) |
 Abdominal discomfort or diarrhoea or gastric irritation (upset stomach) or abdominal pain or nausea or vomiting or dyspepsia, % (n) | 15.4 (10) | 9.7 (8) |
 Restlessness or nervousness or anxiety or depression, % (n) | 13.9 (9) | 9.6 (8) |
 Respiratory disorder, % (n) | 9.2 (6) | 14.5 (12) |
 Myalgia (muscle pain) or muscle spasm, % (n) | 7.7 (5) | 7.2 (6) |
 Skin rashes, % (n) | 3.1 (2) | 9.6 (8) |
 Other symptoms, % (n) | 44.7 (29) | 38.6 (32) |
 Symptoms total, % (n) | 100.0 (100) | 100.0 (107) |